Trial intelligence / Profile preview

Metformin to prevent gestational diabetes and hypertensive disorders in obese pregnant women in Malawi

ISRCTN67684593Phase 3Terminated

Sponsor
University of Edinburgh
Start
Mar 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in gestational diabetes mellitus (GDM) and maternal hypertension (HDP) comparing Metformin with Placebo (2 arms). Started Mar 2020; status: terminated.

02

Drugs

metformin
03

Conditions

gestational diabetes mellitus (GDM)maternal hypertension (HDP)

Beyond the preview

Go deeper on ISRCTN67684593.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN67684593.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call